🇺🇸 Quick-Acting Heart Reliever in United States
2 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 2
Most-reported reactions
- Aspartate Aminotransferase Increased — 1 report (50%)
- Atrioventricular Block First Degree — 1 report (50%)
Other Cardiovascular approved in United States
Frequently asked questions
Is Quick-Acting Heart Reliever approved in United States?
Quick-Acting Heart Reliever does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Quick-Acting Heart Reliever in United States?
Guang'anmen Hospital of China Academy of Chinese Medical Sciences is the originator. The local marketing authorisation holder may differ — check the official source linked above.